Venker Eric Insider Trades & Stock Holdings

Chief Executive Officer · Immunovant, Inc. · Latest filing Oct 2, 2026

Venker Eric, Chief Executive Officer at Immunovant, Inc. has 2 Form 4 trades on file since Sep 30, 2026 across 2 companies. Open-market activity: 0 purchases ($0) and 2 sales ($7.44M), net -$7.44M. Latest filing: disposed of 3.51K shares of $IMVT on Oct 2, 2026 at $34.11.

Trades on file

2

Open-market bought

$0

Open-market sold

$7.44M

Net open-market

-$7.44M

Latest filing

Oct 2, 2026

All insider trades by Venker Eric

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 2, 2026	$IMVT	Sell (Open-market sale)	3.51K	$34.11	$119.59K			-9.4%			Chief Executive Officer		—
Sep 30, 2026	$ROIV	Sell (Open-market sale) 10b5-1	200K	$36.62	$7.32M			-5.0%			President & Immunovant CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Venker Eric traded

• $IMVT
• $ROIV

Frequently asked questions

Has Venker Eric been buying or selling stock?

Venker Eric has 0 open-market purchases and 2 open-market sales on file, net -$7.44M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Venker Eric's latest insider trade?

disposed of 3.51K shares of $IMVT on Oct 2, 2026 at $34.11.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.